Tosi, M., Catteruccia, M., Cherchi, C., Mizzoni, I. and D’Amico, A. 2022. Switching therapies: safety profile of Onasemnogene abeparvovec-xioi in a SMA1 patient previously treated with Risdiplam. Acta Myologica. 41, 3 (Sep. 2022), 117–120. DOI:https://doi.org/10.36185/2532-1900-077.